MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Infectious Disease, Diagnostics, Therapeutics, Pandemic Response, Vaccine Development & Vaccination
2026: Infectious disease expert reveals viruses to worry about as 'super flu' overwhelms US... including one that could put the world 'on cusp of a pandemic'
Chikungunya
Parents
2026: Infectious disease expert reveals viruses to worry about as 'super flu' overwhelms US... including one that could put the world 'on cusp of a pandemic'
Children
*Pioneers: Infectious Diseases _ Chikungunya
2014: DARPA Forecasting Chikungunya Challenge_innocentive
2018: NIH-funded researchers identify target for chikungunya treatment
2020: CEPI commits $14 million for consortium to develop Chikungunya vaccine
2022: Development of a Novel 2-Pyrimidone (SRI-42718) as a Potent Inhibitor of Chikungunya Virus Infection and Disease
2022: Emergent scores a DoD award to evaluate its chikungunya vaccine in the field
2025: 2025 Chikungunya outbreak: A global health challenge
2025: A Debilitating Virus Surges Globally as Mosquitoes Move With Warming Climate
2025: FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live) _ FDA pulls license for chikungunya vaccine
2025: Valneva Is A 'Buy' As A First-Mover In Chikungunya
Alphaviruses are a group of viruses transmitted by mosquitoes and other arthropods that can cause widespread disease outbreaks around the world, with chikungunya, eastern equine encephalitis and o’nyong-nyong as examples that infect humans.
Malaria, Dengue Fever, Chikungunya Fever, and Other Arboviruses
Pandemic & Epidemic Resiliency
Precision Virologics is a vaccine company developing advanced generation adenoviral vaccines. :Precision’s lead agent is a potency enhanced simian adenovirus-based COVID-19 vaccine delivered via the nasal route.: Precision also has vaccine development programs for influenza, Zika, and chikungunya. :Advanced molecular engineering of adenovirus provides technology platforms to provide key advantages.: Precision’s unique capabilities provide ideal positioning for rapid development of effective vaccines for emerging bioweapon and pandemic threats.
Vaccines in earlier preclinical research stages include a chikungunya vaccine, a low-cost human papilloma virus vaccine, a vaccine to protect against new forms of influenza, a combination plague/smallpox vaccine and a West Nile vaccine.